Blikka Genomics

Blikka Genomics

Biotechnology Research

Catalyzing Multi-Omics Evolution Through Smart Enzymatic Design

About us

Blikka Genomics, the newest division of Kura Biotech, operates in the fields of DNA sequencing and controlled enzymatic synthesis. Guided by our vision to catalyze multi-omics evolution through smart enzymatic design, and leveraging Cantera, our state-of-the-art protein engineering platform, Blikka develops high-performance products that drive scientific breakthroughs. Blikka Genomics commitment to precision, innovation, and sustainability ensures researchers have the tools they need to achieve significant advancements in precision medicine and genomics. Join us in catalyzing multi-omics evolution through smart enzymatic design.

Website
www.blikka.com
Industry
Biotechnology Research
Company size
51-200 employees
Founded
2013
Specialties
Genomics, DNA Synthesis, and DNA Sequencing

Updates

Affiliated pages

Similar pages